Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/jpm.2007.0084 | DOI Listing |
J Pain Symptom Manage
February 2025
Institute for Biomedical Technologies (F.C., F.M.), National Research Council, Segrate, Italy. Electronic address:
Medicina (B Aires)
September 2024
Departamento de Neurología Pediátrica, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, España. E-mail:
Rare diseases are characterized by low prevalence and high complexity, affecting millions globally. Although technologies like massive sequencing improve diagnose, therapeutic options remain largely symptomatic or palliative, with few curative treatments approved. In the context of rare diseases, especially genetic neurodevelopmental disorders, therapy development faces obstacles such as phenotypic variability, diverse molecular mechanisms, and complexities in assessing neurodevelopment in natural history and clinical trials.
View Article and Find Full Text PDFMoral courage is defined as the courage to act in ethical conflicts based on individual or professional values despite the personal risks involved. Nurses justify their decisions to act morally courageously as part of their ethical decision-making. To describe registered nurses' justifications for acting morally courageously, or not, in ethical conflicts where they needed moral courage.
View Article and Find Full Text PDFJ Natl Cancer Inst
September 2024
University of Maryland, Baltimore, Baltimore, MD, USA.
Cancer-related cognitive impairment (CRCI) is a broad term encompassing subtle cognitive problems to more severe impairment. CRCI severity is influenced by host, disease, and treatment factors and affects patients prior to, during, and following cancer treatment. The National Cancer Institute (NCI) Symptom Management and Health-Related Quality of Life Steering Committee (SxQoL SC) convened a Clinical Trial Planning Meeting (CTPM) to review the state of the science on CRCI and to develop both Phase II/III intervention trials aimed at improving cognitive function in cancer survivors with non-central nervous system (CNS) disease and longitudinal studies to understand the trajectory of cognitive impairment and contributing factors.
View Article and Find Full Text PDFNeuromodulation
January 2024
Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Objectives: Psychologic screening is often included as a mandatory component of evaluation of the impact of psychopathology disorders on the predicted outcome of spinal cord stimulation (SCS) for patients with chronic pain due to persistent spinal pain syndrome type 2 (PSPS type 2). The conclusion of such screenings can influence the decision to offer SCS therapy to a patient. However, evidence on the impact of psychopathology on SCS outcomes is still scarce.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!